Health Condition 1: G988- Other disorders of nervous system
Conditions
Interventions
Intervention1: Suprabrain: [containing extracts of Jyotisha mati 100mg, Shankspuspi 100 mg, Ashwagandha 50 mg, Brahmi 100 mg, Ginkgo biloba 50 mg and Rhodiola Rosea 100 mg] 500 mg twice a day
Control
Sponsors
M/s Enkel Technology
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects aged 18- 70 years of either sex 2. Able and willing to provide informed consent 3. Subject experiencing subjective cognitive complaints (e.g., forgetfulness, reduced attention, mental fatigue), confirmed by clinician. 4. Subject diagnosed with Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), Dementia, Stroke, Parkinson Disease, Alzheimer s Disease. 5. Patient diagnosed with mild to moderate severity of the specified diagnosis. 6. Capable of completing study questionnaires with or without minimal assistance.
Exclusion criteria
Exclusion criteria: 1. Known hypersensitivity to ingredients of Suprabrain 2. History of drug and alcohol abuse 3. Serious uncontrolled systemic illnesses (e.g., active infection, severe hepatic/renal impairment) 4. Participation in another clinical study within the last 30 days 5. Pregnant or lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in Mini Mental Scale ExaminationTimepoint: 0, 4, 8 and 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Cognitive failure questionnaire, Pittsburgh sleep quality index, Depression Anxiety Stress Scales - 10 item version, WHOQOL-BREF, PSS-10, Anxiety self-rating scale, Serum BDNF, serum NGF.Timepoint: 0, 4, 8 and 12 weeks | — |
Countries
India
Contacts
Public ContactDebasish Hota
AIIMS, Bhubaneswar
Outcome results
None listed